- Home
- BNT vs CRL Comparison
BNT vs CRL Comparison
Compare BNT & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BNT | CRL |
|---|---|---|
| Founded | 2020 | 1947 |
| Country | Bermuda | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.9B | 13.1B |
| IPO Year | 2020 | 1999 |
Fundamental Metrics
Financial Performance| Metric | BNT | CRL |
|---|---|---|
| Price | $36.68 | $297.19 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 18 |
| Target Price | N/A | ★ $315.53 |
| AVG Volume (30 Days) | 9.9K | ★ 929.8K |
| Earning Date | 11-12-2026 | 11-04-2026 |
| Dividend Yield | ★ 0.78% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,857,601,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.55 |
| P/E Ratio | $19.14 | ★ N/A |
| Revenue Growth | N/A | ★ 10.48 |
| 52 Week Low | $35.62 | $146.20 |
| 52 Week High | $49.86 | $333.30 |
Technical Indicators
Market Signals| Indicator | BNT | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 32.63 | 54.82 |
| Support Level | $35.73 | $267.27 |
| Resistance Level | $38.66 | $303.31 |
| Average True Range (ATR) | 0.44 | 11.44 |
| MACD | 0.10 | -0.31 |
| Stochastic Oscillator | 9.89 | 27.68 |
Price Performance
Historical ComparisonAbout BNT Brookfield Wealth Solutions Ltd.
Brookfield Wealth Solutions Ltd, formerly Brookfield Reinsurance Ltd operates a capital solutions business providing insurance and reinsurance services to individuals and institutions. Through its subsidiary, the company offers a broad range of insurance products and services, including life insurance and annuities, and personal and commercial property and casualty insurance. The Company's reporting segments are Annuities, P&C, Life Insurance and Corporate and Other. Majority revenue is generated from Annuities segment followed by P&C.
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.